To better understand the process of osteoarthritic degenerative meniscal lesions (DMLs) formation, this study analyzed the dataset GSE52042 using bioinformatics methods to identify the pivotal genes and pathways related to osteoarthritic DMLs.
Background
The meniscus is an important structure of the knee, playing a pivotal role in shock absorption, joint lubrication and nutrition, proprioception, load transmission, joint congruity, and stability [1] . A meniscus lesion, predisposing to knee osteoarthritis (OA), is a frequent knee joint injury with high incidence rate, found in 60% of patients with asymptomatic osteoarthritis [2] [3] [4] . There is a high interdependency between degenerative meniscal lesions (DMLs) and knee OA [5, 6] . DMLs can be a feature of knee OA and are conducive to joint space narrowing [7] [8] [9] . The best treatment of DMLs is still debated. Although arthroscopic surgery is still widely performed in the management of DMLs [10] , guidelines and research recommend against surgery due to the non-superiority of arthroscopic surgery over non-operative treatment [11] [12] [13] . Biological therapies such as platelet-rich plasma intrameniscal injection may be promising treatments for DMLs [14] . Therefore, better understanding of biological properties and molecular mechanisms in progression of DMLs may promote development of more effective therapeutic strategies.
Recently, microarray technology, which is an effective and highthroughput molecular technique for simultaneously analyzing expression of multiple genes, has been pervasively used in a range of research areas to discover the differentially-expressed genes within molecular mech¬anisms, distinct pathways, and protein-protein interactions (PPI), and to reveal connections between disease and genes [15] [16] [17] [18] [19] [20] . Sun et al. detected many differentially-expressed genes (DEGs) between osteoarthritic meniscal cells and normal meniscal cells [21] . Brophy et al. found the transcripts and biological processes in OA menisci were different from non-OA menisci [22] . Rai et al. revealed a correlation of body mass index to gene expression in ruptured menisci and a biologic association between obesity and knee osteoarthritis [23] . Microarray analysis combined with bioinformatics provides a novel and effective method to investigate the comprehensive molecular mechanisms in meniscus injuries [24] , and may be useful to improve understanding of the connections between DEGs and DMLs.
To explore the molecular mechanisms of DMLs in OA patients, the present study aimed to identify the key DEGs and functional pathways in OA DMLs by use of comprehensive bioinformatics methods. As OA menisci have unique biological properties, we reanalyzed the gene expression profile of GSE52042, which identified the DEGs between diseased or severe degenerative tear OA menisci and healthier OA menisci. Subsequently, extensive bioinformatics analysis was carried out for gene ontology (GO) analysis, reactome pathways identification, PPI network screening, and modules extraction. The results of this work may provide further insights into the pathogenesis of OA DMLs at the molecular level and help explore potential biotherapeutic targets for it. To the best of our knowledge, there is no previously published bioinformatics analysis of this database.
Material and Methods

Microarray data
The GSE52042 dataset in Gene Expression Omnibus (www. ncbi.nlm.nih.gov/geo/) was downloaded for subsequent analysis. GSE52042 was based on GPL17882 platform (Human MI ReadyArray™ 49K Human Genomic Array; Microarrays, Inc., Huntsville, AL, USA), including 4 diseased meniscus samples with thoroughly degraded surfaces and 4 healthier meniscus samples with integrated surfaces, which were obtained from late-stage of knee OA.
Identification of DEGs in diseased and healthier samples
The DEGs between diseased and healthier samples were screened by GEO2R (http://www.ncbi.nlm.nih.gov/geo/geo2r/). P value <0.05 and log fold change (FC) <−1.0 or log FC >1.0 were defined as the cutoff criteria. A volcano plot and a heatmap were constructed using R software (version 3.6.0).
Functional and reactome pathway analysis of DEGs
GO enrichment analysis was carried out by the "ClusterProfiler" package of Bioconductor [25] to assess the potential functions of DEGs in molecular function (MF), cellular component (CC), and biological process (BP). Overrepresented enriched reactome pathways were searched for using the "ReactomePA" package of Bioconductor [26] to identify pathways that were strongly related to DEGs. The P value <0.05 and false discovery rate (FDR) <0.05 were set as the cutoff for criteria.
Construction of PPI network and modules analysis
All DEGs were uploaded to STRING (version 11.0; http://string-db.org/) to evaluate the PPI interactive relationships among DEGs. Confidence score >0.4 was defined as the cutoff criterion. Subsequently, the PPI network was visualized using Cytoscape software (version 3.6.1; www.cytoscape.org). The cytoHubba plugin (version 0.1) [27] was used to extract the hub genes. Then, the modules were extracted using the Molecular Complex Detection plugin (version 1.5.1) according to the criteria: Degree Cutoff=10, Max. Depth=100, K-Core=2, Mode Score Cutoff=0.2, and MCODE score ³4 [28] .
Results
Identification of DEGs
In comparing diseased samples to healthier samples, a total of 154 DEGs including 64 upregulated and 90 downregulated genes were identified from the GSE52042 dataset. The top 10 upregulated and downregulated DEGs are shown in Table 1 . The heatmap and volcano plot for total DEGs are illustrated in Figures 1 and 2 , respectively.
GO terms enrichment analysis
In terms of BP, the upregulated DEGs were primarily participated in female pregnancy, positive regulation of cell cycle, multi-multicellular organism process, positive regulation of mitotic cell cycle, and chromosome segregation, and the downregulated DEGs were chiefly enriched in extracellular matrix (ECM) organization, extracellular structure organization, glycosaminoglycan catabolic process, aminoglycan catabolic process, and keratan sulfate catabolic process.
In terms of CC, the upregulated DEGs were mostly enriched in spindle, midbody, spindle pole, mitotic spindle, and condensed chromosome kinetochore, and the downregulated DEGs were predominantly enriched in collagen-containing extracellular matrix, extracellular matrix, lysosomal lumen, vacuolar lumen, and Golgi lumen.
In terms of MF, the upregulated DEGs were predominantly enriched in ubiquitin-like protein ligase binding. The downregulated DEGs were chiefly involved in extracellular matrix structural constituent, extracellular matrix structural constituent conferring compression resistance, growth factor binding, collagen binding, and glycosaminoglycan binding. 
Reactome pathway analysis
The upregulated DEGs were chiefly enriched in TP53, which regulates transcription of genes involved in G2 cell cycle arrest, condensation of prometaphase chromosomes, nuclear pore complex (NPC) disassembly, resolution of sister chromatid cohesion, and Golgi cisternae pericentriolar stack reorganization, and the downregulated DEGs were predominantly enriched in diseases associated with glycosaminoglycan metabolism, extracellular matrix organization, keratan sulfate degradation, diseases of glycosylation, and keratan sulfate biosynthesis. Table 3 lists the top 10 reactome pathways of the DEGs.
Construction of PPI network and modules analysis
The PPI network was screened, comprising 124 nodes and 355 edges ( Figure 7 ). The top 10 hub genes were identified by cyto-Hubba plugin using the Maximal Clique Centrality (MCC) method, including TYMS, AURKA, CENPN, NUSAP1, CENPM, TPX2, CDK1, UBE2C, BIRC5, and CCNB1 (Table 4, Figure 8 ). Among these genes, Table 5 . 
Discussion
OA is a disease involving the whole joint, and DMLs plays a critical role in the process of knee OA [7] [8] [9] [29] [30] [31] . However, the treatment of DMLs remains a conundrum. Meniscectomy has no benefit over non-operative treatments, while non-operative measures such as nonsteroidal anti-inflammatory drugs, exercise therapy, and rest are the mainstay of management for DMLs [32] . Therefore, better understanding of the underlying pathogenesis of DMLs is of pivotal importance for identification of therapeutic targets and may drive future studies to search for biological treatments of this disease. The high-throughput microarray technology combined with bioinformatics analysis has been widely used in various diseases to predict potential molecular therapeutic targets. In the present study, the microarray dataset GSE52042, comprising healthier and diseased meniscus samples, was obtained, and a bioinformatics analysis was completed. A total of 154 DEGs were identified, including 64 upregulated and 90 downregulated DEGs. Furthermore, in order to probe into the biological significances behind these DEGs, GO, Reactome pathway, and PPI analysis were performed.
In view of the results of GO terms enrichment analysis, we linked the downregulated DEGs with ECM organization, collagen-containing ECM, and ECM structural constituent, and observed the upregulated DEGs had a close relationship with positive regulation of mitotic cell cycle, spindle, and ubiquitin-like protein ligase binding. The meniscus ECM, which plays a crucial role in sustaining structural integrity and mechanical properties of meniscus, is primarily composed of water, collagen, proteoglycan, glycoprotein, elastin, and linking protein [33, 34] . Histopathological analysis showed that degenerated menisci could result in a loss of ECM structure [35] . Herwig and actively dividing cells were found in all recently injured menisci samples and in 1 degenerative menisci sample [44] .
The downregulated DEGs reactome pathways were predominantly involved in diseases associated with glycosaminoglycan metabolism, extracellular matrix organization, keratan sulfate degradation, diseases of glycosylation, and keratan sulfate biosynthesis. These results indicated the disorder of ECM was present in DMLs. Reactome pathway analysis of the upregulated DEGs were predominantly enriched in TP53, which regulates transcription of genes involved in G2 cell cycle arrest, condensation of prometaphase chromosomes, nuclear pore complex (NPC) disassembly, resolution of sister chromatid cohesion, and Golgi cisternae pericentriolar stack reorganization, and these were related to cell proliferation, consistent with the results of GO terms enrichment analysis of upregulated DEGs.
The PPI network was screened to predict the connections of protein functions of DEGs, and the top 10 hub genes -TYMS, AURKA, CENPN, NUSAP1, CENPM, TPX2, CDK1, UBE2C, BIRC5, and CCNB1 -were presented. Some hub genes are closely associated with osteoarthritic chondrocytes. Cyclin-dependent kinase 1 (CDK1), a highly conserved small protein, is a member of the cyclin-dependent kinase family that serves as a serine/threonine kinase and the catalytic subunit of mitosisphase promoting factor, playing a pivotal role in controlling cell cycle, such as mitotic onset and driving G2-M transition [45] [46] [47] [48] [49] . CDK1 was detected in human and rat osteoarthritic chondrocytes [50] . Saito et al. demonstrated that overexpression of CDK1 could cause chondrocyte proliferation, and its low expression could result in chondrocyte differentiation and maturity, indicating CDK1 was essential for chondrocytes proliferation and differentiation [51] . Cyclin B1 (CCNB1) is one of cell cycle proteins which are essential regulators of cell division, and complexes with CDK1 to form a mitosis-phase-promoting factor that promotes mitosis [46, 47] . Zhou et al. found that platelets could upregulate the proliferation of rat osteoarthritic chondrocytes via stimulation of the ERK/CDK1/CCNB1 pathway [52] . Baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5), also called survivin, is a protein that belongs to the inhibitor of apoptosis family, which localizes to the spindle, expressed in the G2/M phase, and plays a key role in the regulation of mitosis and protection of cells from apoptosis [53, 54] . BIRC5 was detected in human osteoarthritic chondrocytes, and its suppression expression can lead to reduced rates of chondrocyte proliferation and G2/M blockade [55] . Aurora kinase A (AURKA) is a type of Aurora kinase and is crucial for the successful execution of mitosis [56] . AURKA was highly expressed in human osteoarthritic chondrocytes and overexpression of AURKA could contributes to the development of knee osteoarthritis [57] . In the present study, AURKA, CDK1, BIRC5, and CCNB1 were upregulated in diseased menisci compared to healthier menisci in late-stage knee OA, indicating diseased meniscus cells tended to cell proliferation.
Two modules were extracted from the PPI network. Most of the genes presented in module 1 are the aforementioned hub genes. The genes in module 2 relate to ECM metabolism. Matrix metalloproteinase-2 (MMP2) is a matrix metalloproteinase with ECM-degrading components [58] . Stone 8902 knee joints [65] . Endo et al. observed that LUM was upregulated in menisci in early-phase knee OA [66] . Hellio observed that the FMOD expression was downregulated in the lateral meniscus at 3 weeks after anterior cruciate ligament transection for experimental OA in rabbits, but returned to normal at 8 weeks after surgery [67] . Aggrecan (ACAN) is a macromolecular proteoglycan and a crucial component of meniscus ECM, helping to maintain biomechanical properties of ECM [68] [69] [70] [71] . Favero et al. found that OA meniscus and synovium could release inflammatory molecules to induce meniscus ACAN degradation and ECM loss [72] . Freymann et al. observed that human serum could stimulate meniscal cells obtained from advanced degenerative menisci in end-stage OA patients to express aggrecan [73] . In the present study, LUM, FMOD, and ACAN were downregulated in diseased menisci compared to healthier menisci in late-stage knee OA, indicating the ECM structure was impaired in diseased menisci.
According to the present results, some of the genes promoting cell proliferation were upregulated, while some of the genes constituting meniscus ECM were downregulated in the diseased meniscus samples, indicating that cell repair and ECM degradation may coexist in the process of osteoarthritic DMLs, which reflected the disorder of cell proliferation and the impairment of ECM integrality in osteoarthritic DMLs. Better understanding of these unique biological features may help develop potential therapies for osteoarthritic DMLs.
Conclusions
We conducted a comprehensive bioinformatics analysis on gene expression profile of OA meniscus. Key genes and pathways were identified to provide more detailed molecular mechanisms for the process of osteoarthritic DMLs and shed light on potential therapeutic targets. Nevertheless, further experiments are needed to further validate the identified genes and pathways.
